Identification of immune subtypes to guide immunotherapy and targeted therapy in clear cell renal cell carcinoma-Reference-Cited by-同舟云学术

Identification of immune subtypes to guide immunotherapy and targeted therapy in clear cell renal cell carcinoma

Published:2022-09-01 Issue:17 Volume:14 Page:6917-6935
ISSN:1945-4589
Container-title:Aging
language:en
Short-container-title:Aging

Author:

Xu Chen¹,Li Yang²,Su Wei³,Wang Zhenfan¹,Ma Zheng¹,Zhou Lei¹,Zhou Yongqiang¹,Chen Jianchun¹,Jiang Minjun¹,Liu Ming⁴

Affiliation:

1. Department of Urology, Suzhou Ninth People’s Hospital, Soochow University, Suzhou 215000, China

2. Department of Urology, Shanghai Pudong Hospital, Fudan University Pudong Medical Center, Huinan Town, Pudong, Shanghai 201399, China

3. Department of Medical Oncology, Fudan University Shanghai Cancer Center, Shanghai 200032, China

4. The State Key Laboratory of Pharmaceutical Biotechnology, Department of Hematology, The Affiliated Drum Tower Hospital of Nanjing University Medical School, China-Australia Institute of Translational Medicine, School of Life Sciences, Nanjing University, Nanjing 210023, China

Publisher

Impact Journals, LLC

Subject

Cell Biology,Aging

Reference48 articles.

1. Cancer Statistics, 2021.;Jemal;CA Cancer J Clin,2021

2. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.;Jemal;CA Cancer J Clin,2018

3. The Clinicopathologic and Molecular Landscape of Clear Cell Papillary Renal Cell Carcinoma: Implications in Diagnosis and Management.;Reznik;Eur Urol,2021

4. European Association of Urology Guidelines for Clear Cell Renal Cancers That Are Resistant to Vascular Endothelial Growth Factor Receptor-Targeted Therapy.;Merseburger;Eur Urol,2016

5. Anti-angiogenic agents - overcoming tumour endothelial cell anergy and improving immunotherapy outcomes.;Griffioen;Nat Rev Clin Oncol,2021

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. VSIG4 induces the immunosuppressive microenvironment by promoting the infiltration of M2 macrophage and Tregs in clear cell renal cell carcinoma;International Immunopharmacology;2024-12

2. Identification and validation of prognostic signature genes of bladder cancer by integrating methylation and transcriptomic analysis;Scientific Reports;2024-01-03

3. Construction and validation of a model based on immunogenic cell death-associated lncRNAs to predict prognosis and direct therapy for kidney renal clear cell carcinoma;Aging;2023-06-27

4. Galaxolide and Irgacure 369 are novel environmental androgens;Chemosphere;2023-05